P50 Quantifying Treatment Value Using Alternative Health Benefit Metrics: A Case Study of Adjuvant Osimertinib for Elderly Patients with EGFR mutated NSCLC Following Resection
Abstract
Authors
Rahul Shenolikar Rachel Salomonsen Anuj Shah Shanshan Wang Stephanie Wise Sukhvinder S. Johal Sara Sullivan Sanjana Muthukrishnan Jason Shafrin